112 related articles for article (PubMed ID: 2297726)
1. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
[TBL] [Abstract][Full Text] [Related]
2. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
[TBL] [Abstract][Full Text] [Related]
3. An instant kit method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model.
Pak KY; Nedelman MA; Kanke M; Khaw BA; Mattis JA; Strauss HW; Dean RT; Berger HJ
J Nucl Med; 1992 Jan; 33(1):144-9. PubMed ID: 1730981
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m labeling of murine monoclonal antibody fragments.
Rhodes BA; Zamora PO; Newell KD; Valdez EF
J Nucl Med; 1986 May; 27(5):685-93. PubMed ID: 3086522
[TBL] [Abstract][Full Text] [Related]
5. Preparation of a pure 99mTc-F(ab')2 radioimmunoconjugate by direct labeling methods.
Griffiths GL; Goldenberg DM; Jones AL; Hansen HJ
Nucl Med Biol; 1994 May; 21(4):649-55. PubMed ID: 9234323
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the 323/A3 monoclonal antibody and the use of technetium-99m-labeled 323/A3 Fab' for the detection of pan adenocarcinoma.
Pak KY; Nedelman MA; Fogler WE; Tam SH; Wilson E; Van Haarlem LJ; Colognola R; Warnaar SO; Daddona PE
Int J Rad Appl Instrum B; 1991; 18(5):483-97. PubMed ID: 1917518
[TBL] [Abstract][Full Text] [Related]
7. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
Lerthirunwong C; Cheng KT; Hladik WB
Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m.
Griffiths GL; Goldenberg DM; Roesch F; Hansen HJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3001s-3003s. PubMed ID: 10541334
[TBL] [Abstract][Full Text] [Related]
9. Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
Govindan SV; Goldenberg DM; Grebenau RC; Hansen HJ; Griffiths GL
Bioconjug Chem; 1996; 7(3):290-7. PubMed ID: 8816950
[TBL] [Abstract][Full Text] [Related]
10. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.
Kasina S; Rao TN; Srinivasan A; Sanderson JA; Fitzner JN; Reno JM; Beaumier PL; Fritzberg AR
J Nucl Med; 1991 Jul; 32(7):1445-51. PubMed ID: 2066805
[TBL] [Abstract][Full Text] [Related]
11. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
13. A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodies.
Ram S; Buchsbaum DJ
Cancer; 1994 Feb; 73(3 Suppl):769-73. PubMed ID: 8306258
[TBL] [Abstract][Full Text] [Related]
14. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
[TBL] [Abstract][Full Text] [Related]
15. A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer.
Scollard DA; Chan C; Holloway CM; Reilly RM
Nucl Med Biol; 2011 Jan; 38(1):129-36. PubMed ID: 21220136
[TBL] [Abstract][Full Text] [Related]
16. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
[TBL] [Abstract][Full Text] [Related]
17. Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results.
Kumar P; Singh B; Ghai A; Hazari PP; Mittal BR; Mishra AK
J Labelled Comp Radiopharm; 2015 May; 58(6):242-9. PubMed ID: 25968484
[TBL] [Abstract][Full Text] [Related]
18. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method.
Pak KY; Nedelman MA; Tam SH; Wilson E; Daddona PE
Int J Rad Appl Instrum B; 1992 Aug; 19(6):669-77. PubMed ID: 1522021
[TBL] [Abstract][Full Text] [Related]
19. Direct labeling of proteins with 99mTc.
Rhodes BA
Int J Rad Appl Instrum B; 1991; 18(7):667-76. PubMed ID: 1787075
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of 99mTc(Sn)- and 131I-labeled anti-carcinoembryonic antigen monoclonal antibody fragments in nude mice.
Zimmer AM; Kazikiewicz JM; Rosen ST; Spies SM
Cancer Res; 1987 Mar; 47(6):1691-4. PubMed ID: 3815365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
